The groundbreaking treatment of the medication represents a major development in the management of type 2 diabetes. Different to existing drugs, tirzepatide affects multiple pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide922119.slypage.com/42578139/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment